KERALA AYURVEDA
Back to Balance Sheet
|
KERALA AYURVEDA Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹88 Cr | ₹40 Cr | ₹53 Cr | ₹60 Cr | ₹42 Cr |
What is the latest Total Current Liabilities ratio of KERALA AYURVEDA ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹88 Cr |
| Mar2024 | ₹40 Cr |
| Mar2023 | ₹53 Cr |
| Mar2022 | ₹60 Cr |
| Mar2021 | ₹42 Cr |
How is Total Current Liabilities of KERALA AYURVEDA Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹88 Cr | 117.74 | |
| Mar2024 | ₹40 Cr | -23.32 | |
| Mar2023 | ₹53 Cr | -12.60 | |
| Mar2022 | ₹60 Cr | 43.83 | |
| Mar2021 | ₹42 Cr | - | |
Compare Total Current Liabilities of peers of KERALA AYURVEDA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KERALA AYURVEDA | ₹191.1 Cr | -4.1% | -15.2% | -67.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,283.0 Cr | 0.2% | -4.1% | 5.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹244,762.0 Cr | -3.1% | -1.6% | 47.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,448.0 Cr | -1.2% | -5% | 29.4% | Stock Analytics | |
| CIPLA | ₹107,043.0 Cr | 2.3% | -2% | -13.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,820.0 Cr | 2.2% | 6.2% | -2.5% | Stock Analytics | |
KERALA AYURVEDA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KERALA AYURVEDA | -4.1% |
-15.2% |
-67.6% |
| SENSEX | 3.8% |
-0.6% |
-9.1% |
You may also like the below Video Courses